Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ryan

Showing results (961-970 of 1,067) with videos related to

Pageof 107
Sort By:
Nature Biotechnology|June 30, 2015
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cellsAyal Hendel, Rasmus O Bak, Joseph T Clark, et al.
Cell|May 17, 1996
Agrin acts via a MuSK receptor complexDavid J Glass, David C Bowen, Trevor N Stitt, et al.
Cancer Research|March 1, 1980
Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compoundsA W Wood, W Levin, R L Chang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 3, 2016
Microsatellite instability is associated with reduced disease specific survival in stage III colon cancerH M Mohan, E Ryan, I Balasubramanian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 15, 2018
Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34<sup>+</sup> Hematopoietic Stem and Progenitor CellsM Kyle Cromer, Sriram Vaidyanathan, Daniel E Ryan, et al.
Circulation Research|June 16, 2023
Activation of the Aryl Hydrocarbon Receptor in Muscle Exacerbates Ischemic Pathology in Chronic Kidney DiseaseNicholas Balestrieri, Victoria Palzkill, Caroline Pass, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Chronic activation of the aryl hydrocarbon receptor in muscle exacerbates ischemic pathology in chronic kidney diseaseNicholas Balestrieri, Victoria Palzkill, Caroline Pass, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 19, 2022
CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of TreatmentD Swan, R Henderson, C McEllistrim, et al.
AJNR. American Journal of Neuroradiology|March 26, 2026
ACR-ASNR-SNIS-SPR Practice Parameter for the Performance of Magnetic Resonance Angiography (MRA) of the Head and NeckReade Andrew De Leacy, Colin Segovis, Aparna Singhal, et al.
Nucleic Acids Research|December 8, 2017
Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAsDaniel E Ryan, David Taussig, Israel Steinfeld, et al.
Pageof 107

Showing results (961-970 of 1,067) with videos related to

Sort By:
Pageof 107
Nature Biotechnology|June 30, 2015
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cellsAyal Hendel, Rasmus O Bak, Joseph T Clark, et al.
Cell|May 17, 1996
Agrin acts via a MuSK receptor complexDavid J Glass, David C Bowen, Trevor N Stitt, et al.
Cancer Research|March 1, 1980
Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compoundsA W Wood, W Levin, R L Chang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 3, 2016
Microsatellite instability is associated with reduced disease specific survival in stage III colon cancerH M Mohan, E Ryan, I Balasubramanian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 15, 2018
Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34<sup>+</sup> Hematopoietic Stem and Progenitor CellsM Kyle Cromer, Sriram Vaidyanathan, Daniel E Ryan, et al.
Circulation Research|June 16, 2023
Activation of the Aryl Hydrocarbon Receptor in Muscle Exacerbates Ischemic Pathology in Chronic Kidney DiseaseNicholas Balestrieri, Victoria Palzkill, Caroline Pass, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Chronic activation of the aryl hydrocarbon receptor in muscle exacerbates ischemic pathology in chronic kidney diseaseNicholas Balestrieri, Victoria Palzkill, Caroline Pass, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 19, 2022
CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of TreatmentD Swan, R Henderson, C McEllistrim, et al.
AJNR. American Journal of Neuroradiology|March 26, 2026
ACR-ASNR-SNIS-SPR Practice Parameter for the Performance of Magnetic Resonance Angiography (MRA) of the Head and NeckReade Andrew De Leacy, Colin Segovis, Aparna Singhal, et al.
Nucleic Acids Research|December 8, 2017
Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAsDaniel E Ryan, David Taussig, Israel Steinfeld, et al.
Pageof 107